ClinVar Miner

Submissions for variant NM_170707.4(LMNA):c.1608+5G>A

gnomAD frequency: 0.00001  dbSNP: rs267607539
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000619007 SCV000737304 likely pathogenic Cardiovascular phenotype 2017-09-14 criteria provided, single submitter clinical testing The c.1608+5G>A intronic variant results from a G to A substitution 5 nucleotides after coding exon 9 in the LMNA gene. This alteration has been reported in an individual with limb-girdle muscular dystrophy (LGMD1B) whose fibroblasts show blebbing of the nuclear envelope (Muchir A et al. Muscle Nerve. 2004;30:444-50). In addition, a disease-causing mutation at the same splice site, c.1608+5G>C, has been shown to impact splicing, causing retention of intron 9 and leading to a frameshift and premature truncation of the LMNA protein (Muchir A et al. Hum. Mol. Genet. 2000;9:1453-9). This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, the c.1608+5G>A alteration is predicted to weaken the efficiency of the native splice donor site; however, direct evidence is unavailable. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.